- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06295185
Digital Therapeutic Workplace Technology as a Employee Management Tool and Employee's Mental Health Care
How Social Ventures Boost Performance and Sustain Businesses With Digital Therapeutic Workplace Technology (Smartphone App 'Maro') Designed to Support Individual Employee's Mental Health
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hisbeans is a social enterprise where employees are consist of individual with mental disabilities.
'Hisbeans' employees(N = 150 subjects) will be randomly assigned to Group 1 (maro intervention), or Group 2 (control app intervention) by cluster randomization depending on the branch of the company.
- MARO intervention group: MARO (mental health digital application) use
- Control group: sham app use
The intervention period will be 8weeks.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yong Hyuk Choi, MD
- Phone Number: +82-31-219-5182
- Email: brainist.cho@gmail.com
Study Contact Backup
- Name: Anna You
- Phone Number: +82-31-219-4696
- Email: uanna@ajou.ac.kr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- HISBEANS store employees
- Age: 18 years old or older
- possessing a smartphone with internet connection
- subjects agree to participate in the study
Exclusion Criteria:
- Those who have symptoms of psychotic disorder are acutely active or advanced, making clinical intervention difficult
- Those who has been started or changed their antidepressant medication within the last 1 month or cannot be maintained stably during the intervention period
- Those who are non-literate
- Those who have used the Maro app previously
- Those who couldn't use Maro app in their own smartphone
- Those who participate in another intervention study
- Those who have a serious medical condition that prevents them from participating in the intervention and efficacy evaluation
- Those who is unable to participate fully and cooperatively by the judgment of the researcher
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: mental health treated with digital intervention app 'Maro'
Intervention group will use 'Maro app' which was developed to improve mental health for 8weeks. Through 8weeks intervention group will record their status more than once a day and utilize specific functions in the app. They will also have meetings once a week in the online chat in order to share their own experience about Maro application use with other employees in the same branch. |
It is a mental healthcare application aim to improve mental health.
|
Sham Comparator: Digital Sham App
Control group will use Sham app for 8weeks.
|
It is a sham application in order to control spill over bias.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in network on the Standard Name Generator Approach scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in depression symptoms severity on the Patient Health Questionnaire-9
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in social capital on the Social Capital Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in perceived workload on the Perceived Workload Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in job self-efficacy on the Job Self-Efficacy Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in sense of meaningfulness for job on the Sense of Meaningfulness for Job Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in work orientation toward his or her job on the Work Orientation Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in sense of psychological safety on the Perception of Psychological Safety Scale of Company Employees
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in firm performance on the Company weekly sales records
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in amsenteeism/leaves on the absenteeism/leave scales for employees with severe mental disabilities
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in stress regulation skill on the Emotional/Cognitive/Behavioral State Questionnaire
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in anxiety symptoms severity on the General Anxiety Disorder-7items scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in perceived stress level on the Perceived Stress Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in social functioning on Social Adaptation Self Rating Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in positive psychological capital on Korean version of Positive Psychological Capital Scale
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in Organizational Companionship on Organizational Culture Inventory
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Change in individual's social network on Lubben Social Network Scale-18
Time Frame: 4weeks, 8weeks after starting treatment
|
|
4weeks, 8weeks after starting treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Chang Hyung Hong, Ph.D, Ajou Medical Center
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AJOUIRB-IV-2024-097
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on application MARO
-
Johns Hopkins UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Vanderbilt... and other collaboratorsActive, not recruitingNephrectomy | Kidney | Living DonorsUnited States
-
Universidad Católica San Antonio de MurciaNot yet recruitingPhysical Activity | Adolescent Behavior | New Technologies
-
Assiut UniversityCompletedImproving Quality of LifeEgypt
-
University of North Carolina, Chapel HillCompleted
-
Kars State HospitalCompletedExercise | Ultrasound | KinesiotapeTurkey
-
Ataturk Training and Research HospitalNot yet recruiting
-
TC Erciyes UniversityCompleted
-
patientMpower Ltd.Health Service Executive, IrelandCompleted
-
The University of Hong KongCompletedEarly Childhood CariesHong Kong